Singapore Healthcare Contract Research Organization Market Size & Outlook

The healthcare contract research organization market in Singapore is expected to reach a projected revenue of US$ 2,933.4 million by 2030. A compound annual growth rate of 8.2% is expected of Singapore healthcare contract research organization market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,685.4
Forecast, 2030 (US$M)
$2,933.4
CAGR, 2024 - 2030
8.2%
Report Coverage
Singapore

Singapore healthcare contract research organization market, 2018-2030 (US$M)

Singapore

Related Markets

Singapore healthcare contract research organization market highlights

  • The Singapore healthcare contract research organization market generated a revenue of USD 1,685.4 million in 2023 and is expected to reach USD 2,933.4 million by 2030.
  • The Singapore market is expected to grow at a CAGR of 8.2% from 2024 to 2030.
  • In terms of segment, clinical was the largest revenue generating type in 2023.
  • Pre-Clinical is the most lucrative type segment registering the fastest growth during the forecast period.


Healthcare contract research organization market data book summary

Market revenue in 2023USD 1,685.4 million
Market revenue in 2030USD 2,933.4 million
Growth rate8.2% (CAGR from 2023 to 2030)
Largest segmentClinical
Fastest growing segmentPre-Clinical
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDrug Discovery, Pre-Clinical, Clinical
Key market players worldwideIcon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, GVK Biosciences, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, PAREXEL, Dassault Systemes SE, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, SGS AG, Worldwide Clinical Trials, Wuxi AppTec Co Ltd, Caidya


Other key industry trends

  • In terms of revenue, Singapore accounted for 3.3% of the global healthcare contract research organization market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan healthcare contract research organization market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 4,181.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Healthcare Contract Research Organization Market Scope

Healthcare contract research organization market segmentation & scope
Target validation
Lead identification
Lead optimization
Pre-Clinical
Phase I Trial Services
Phase II Trial Services
Phase III Trial Services
Phase IV Trial Services
Project Management/Clinical Supply Management
Data Management
Regulatory/Medical Affairs
Medical Writing
Clinical Monitoring
Quality Management/ Assurance
Bio-statistics
Investigator Payments
Sterility Testing
Container/Closure Testing
Extractables and Leachable Testing
Environmental Monitoring (Including Microbiology Testing)
Disinfectant Efficacy Studies
Other
Patient and site Recruitment
Technology
Others
Oncology
CNS Disorders
Infectious Diseases
Immunological Disorders
Cardiovascular Disease
Respiratory Diseases
Diabetes
Ophthalmology
Pain Management
Other
Molecule Type
Pharmaceutical
Small Molecules
Biologics
Medical Device

Healthcare Contract Research Organization Market Companies

Name Profile # Employees HQ Website

Singapore healthcare contract research organization market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract research organization market will help companies and investors design strategic landscapes.


Clinical was the largest segment with a revenue share of 76.04% in 2023. Horizon Databook has segmented the Singapore healthcare contract research organization market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.


The pharmaceutical industry is increasingly drawn to Singapore due to its research & innovation, trusted regulatory & IP environment, and good talent base. Singapore is a lucrative market for preclinical CRO services.

However, the registration process can be a challenge. Unlike other countries, Singapore still depends on in-country testing and its clinical data to approve drugs, even if the drug is already being sold in other major markets.

Moreover, increasing number of drugs entering preclinical trials and rising pressure to reduce R&D expenses are among factors expected to contribute to the increasing demand for preclinical CRO services, thereby boosting the market.

Reasons to subscribe to Singapore healthcare contract research organization market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Singapore healthcare contract research organization market databook

  • Our clientele includes a mix of healthcare contract research organization market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Singapore healthcare contract research organization market , including forecasts for subscribers. This country databook contains high-level insights into Singapore healthcare contract research organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Singapore healthcare contract research organization market size, by type, 2018-2030 (US$M)

Singapore Healthcare Contract Research Organization Market Outlook Share, 2023 & 2030 (US$M)

Singapore healthcare contract research organization market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more